Form 4: BIO-KEY International Director Emmanuel Alia Receives Restricted Stock Grant

Emmanuel Alia, a Director at BIO-KEY International Inc., was granted 5,000 shares of restricted common stock on May 27, 2025, as part of the company's 2023 Stock Incentive Plan.

Summary

• Emmanuel Alia, a Director of BIO-KEY INTERNATIONAL INC (BKYI), acquired 5,000 shares of common stock on May 27, 2025.
• The acquisition was a grant of Restricted Stock at a price of $0 per share, indicating it was part of a compensation plan.
• These 5,000 shares were granted under the Issuer's 2023 Stock Incentive Plan.
• The restricted stock will vest in three equal annual installments on each of the next three anniversaries of the grant date.
• Vesting is subject to Mr. Alia's continued employment with or service to BIO-KEY International Inc. through the applicable vesting date.
• Following this transaction, Emmanuel Alia beneficially owns 21,323 shares of common stock.
• The reported holdings do not include options to purchase an additional 18 shares.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director is a positive signal for corporate governance and long-term alignment of interests, indicating management's commitment to retaining key personnel. It's a routine, expected event, not a major catalyst, hence a moderately positive score.

Positives

• The grant of restricted stock aligns the director's interests with long-term shareholder value, as the value of the shares is tied to the company's future performance.
• The transaction is part of a formal 2023 Stock Incentive Plan, indicating a structured approach to executive and director compensation.
• The three-year vesting schedule encourages continued service and commitment from the director, promoting stability in leadership.

Negatives

• The director did not receive immediate cash from this transaction, as it was a stock grant rather than a sale.
• The ultimate value of the grant to the director is contingent on the future stock price performance of BKYI and the fulfillment of vesting conditions.

Risks

• The vesting of the 5,000 restricted shares is contingent upon Emmanuel Alia's continued employment or service to BIO-KEY International Inc., meaning the shares could be forfeited if service ceases before vesting.
• The market value of the granted shares is subject to the inherent volatility and risks associated with BIO-KEY International Inc.'s common stock.

Future Outlook

The vesting schedule for the restricted stock grant indicates a commitment to retaining key personnel, with shares vesting over the next three years, contingent on continued service, which supports long-term strategic continuity.

Industry Context

This transaction is a standard practice in corporate compensation, where equity grants are used to incentivize and retain directors and executives, aligning their interests with long-term company performance. Such grants are common across various industries, particularly in technology and software sectors like BIO-KEY's, to foster commitment and reward contributions.

Comparison to Industry Standards

• Equity grants to directors, such as the restricted stock granted to Emmanuel Alia, are a common compensation practice across publicly traded companies, particularly in the technology sector.
• While specific grant sizes vary based on company size, director responsibilities, and compensation philosophy, the use of multi-year vesting schedules is standard to promote long-term alignment and retention.
• Companies like Okta (OKTA), Ping Identity (PING), and ForgeRock (FORG) (before its acquisition) in the identity and access management space often utilize similar equity-based compensation structures for their board members to ensure their commitment to strategic objectives and shareholder value creation.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with long-term shareholder value through equity ownership and performance-based vesting.
• Employees: While specific to a director, such incentive plans can signal a company's commitment to equity-based compensation, potentially impacting broader employee retention strategies.
• Management: Reinforces the company's strategy for executive and director compensation and retention.

Next Steps

• The restricted stock will vest in three equal annual installments on the next three anniversaries of the grant date, subject to continued service.

Key Dates

Recommendation

Keywords

BIO-KEY International, BKYI, Form 4, SEC filing, insider transaction, restricted stock, stock incentive plan, corporate governance, director compensation, equity grant